Alyeska Investment Group’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-173,591	Closed	-$4.67M	–	525
2018 Q2	$4.67M	Buy	173,591 +53,962	+45%	+$1.45M	0.04%	264
2018 Q1	$3.81M	Buy	+119,629	New	+$3.81M	0.03%	286
2015 Q4	–	Sell	-50,000	Closed	-$1.27M	–	492
2015 Q3	$1.27M	Buy	+50,000	New	+$1.27M	0.01%	362